Kara L. Mungovan
Lawyers
Filters
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Valaris $700 million senior secured second-lien notes offering
The high-yield senior secured second-lien notes are due 2030
UBS $3.2 billion acquisition of Credit Suisse
We are advising UBS on the transaction
Advance Auto Parts $600 million notes offering
The notes are due 2026 and 2028
Verisk $500 million senior notes offering
We advised Verisk on the SEC-registered notes
Alteryx $450 million senior notes offering
The 8.75% notes are due 2028
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Semtech $1.815 billion Sierra Wireless acquisition financing
We advised Semtech on a new term loan facility, the amendment to its revolver and its issuance of convertible notes